Skip to main content
Title Pub Year Sort ascending Author SearchLink
Workplace interventions for smoking cessation 2014 Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, UK, OX2 6GG.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
The Cochrane database of systematic reviews
Periodical, Abbrev.
Cochrane Database Syst.Rev.
Pub Date Free Form
26-Feb
Volume
(2):CD003440. doi
Issue
2
Start Page
CD003440
Other Pages
Notes
LR: 20160602; GR: Department of Health/United Kingdom; JID: 100909747; epublish
Place of Publication
England
ISSN/ISBN
1469-493X; 1361-6137
Accession Number
PMID: 24570145
Language
eng
SubFile
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; IM
DOI
10.1002/14651858.CD003440.pub4 [doi]
Output Language
Unknown(0)
PMID
24570145
Abstract
BACKGROUND: The workplace has potential as a setting through which large groups of people can be reached to encourage smoking cessation. OBJECTIVES: 1. To categorize workplace interventions for smoking cessation tested in controlled studies and to determine the extent to which they help workers to stop smoking.2. To collect and evaluate data on costs and cost effectiveness associated with workplace interventions. SEARCH METHODS: We searched the Cochrane Tobacco Addiction Group Specialized Register (July 2013), MEDLINE (1966 - July 2013), EMBASE (1985 - June 2013), and PsycINFO (to June 2013), amongst others. We searched abstracts from international conferences on tobacco and the bibliographies of identified studies and reviews for additional references. SELECTION CRITERIA: We selected interventions conducted in the workplace to promote smoking cessation. We included only randomized and quasi-randomized controlled trials allocating individuals, workplaces, or companies to intervention or control conditions. DATA COLLECTION AND ANALYSIS: One author extracted information relating to the characteristics and content of all kinds of interventions, participants, outcomes and methods of the studies, and a second author checked them. For this update we have conducted meta-analyses of the main interventions, using the generic inverse variance method to generate odds ratios and 95% confidence intervals. MAIN RESULTS: We include 57 studies (61 comparisons) in this updated review. We found 31 studies of workplace interventions aimed at individual workers, covering group therapy, individual counselling, self-help materials, nicotine replacement therapy, and social support, and 30 studies testing interventions applied to the workplace as a whole, i.e. environmental cues, incentives, and comprehensive programmes. The trials were generally of moderate to high quality, with results that were consistent with those found in other settings. Group therapy programmes (odds ratio (OR) for cessation 1.71, 95% confidence interval (CI) 1.05 to 2.80; eight trials, 1309 participants), individual counselling (OR 1.96, 95% CI 1.51 to 2.54; eight trials, 3516 participants), pharmacotherapies (OR 1.98, 95% CI 1.26 to 3.11; five trials, 1092 participants), and multiple intervention programmes aimed mainly or solely at smoking cessation (OR 1.55, 95% CI 1.13 to 2.13; six trials, 5018 participants) all increased cessation rates in comparison to no treatment or minimal intervention controls. Self-help materials were less effective (OR 1.16, 95% CI 0.74 to 1.82; six trials, 1906 participants), and two relapse prevention programmes (484 participants) did not help to sustain long-term abstinence. Incentives did not appear to improve the odds of quitting, apart from one study which found a sustained positive benefit. There was a lack of evidence that comprehensive programmes targeting multiple risk factors reduced the prevalence of smoking. AUTHORS' CONCLUSIONS: 1. We found strong evidence that some interventions directed towards individual smokers increase the likelihood of quitting smoking. These include individual and group counselling, pharmacological treatment to overcome nicotine addiction, and multiple interventions targeting smoking cessation as the primary or only outcome. All these interventions show similar effects whether offered in the workplace or elsewhere. Self-help interventions and social support are less effective. Although people taking up these interventions are more likely to stop, the absolute numbers who quit are low.2. We failed to detect an effect of comprehensive programmes targeting multiple risk factors in reducing the prevalence of smoking, although this finding was not based on meta-analysed data. 3. There was limited evidence that participation in programmes can be increased by competitions and incentives organized by the employer, although one trial demonstrated a sustained effect of financial rewards for attending a smoking cessation
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Cahill,K., Lancaster,T.
Original/Translated Title
URL
Date of Electronic
20140226
PMCID
Editors
Acupuncture and related interventions for smoking cessation 2014 Primary Care, Plymouth University Peninsula Schools of Medicine and Dentistry, 25 Room N32, ITTC Building, Tamar Science Park, Plymouth, UK, PL6 8BX.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
The Cochrane database of systematic reviews
Periodical, Abbrev.
Cochrane Database Syst.Rev.
Pub Date Free Form
23-Jan
Volume
(1):CD000009. doi
Issue
1
Start Page
CD000009
Other Pages
Notes
LR: 20160602; JID: 100909747; epublish
Place of Publication
England
ISSN/ISBN
1469-493X; 1361-6137
Accession Number
PMID: 24459016
Language
eng
SubFile
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; IM
DOI
10.1002/14651858.CD000009.pub4 [doi]
Output Language
Unknown(0)
PMID
24459016
Abstract
BACKGROUND: Acupuncture and related techniques are promoted as a treatment for smoking cessation in the belief that they may reduce nicotine withdrawal symptoms. OBJECTIVES: The objectives of this review are to determine the effectiveness of acupuncture and the related interventions of acupressure, laser therapy and electrostimulation in smoking cessation, in comparison with no intervention, sham treatment, or other interventions. SEARCH METHODS: We searched the Cochrane Tobacco Addiction Group Specialized Register (which includes trials of smoking cessation interventions identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and PsycINFO) and AMED in October 2013. We also searched four Chinese databases in September 2013: Sino-Med, China National Knowledge Infrastructure, Wanfang Data and VIP. SELECTION CRITERIA: Randomized trials comparing a form of acupuncture, acupressure, laser therapy or electrostimulation with either no intervention, sham treatment or another intervention for smoking cessation. DATA COLLECTION AND ANALYSIS: We extracted data in duplicate on the type of smokers recruited, the nature of the intervention and control procedures, the outcome measures, method of randomization, and completeness of follow-up.We assessed abstinence from smoking at the earliest time-point (before six weeks) and at the last measurement point between six months and one year. We used the most rigorous definition of abstinence for each trial, and biochemically validated rates if available. Those lost to follow-up were counted as continuing smokers. Where appropriate, we performed meta-analysis pooling risk ratios using a fixed-effect model. MAIN RESULTS: We included 38 studies. Based on three studies, acupuncture was not shown to be more effective than a waiting list control for long-term abstinence, with wide confidence intervals and evidence of heterogeneity (n = 393, risk ratio [RR] 1.79, 95% confidence interval [CI] 0.98 to 3.28, I(2) = 57%). Compared with sham acupuncture, the RR for the short-term effect of acupuncture was 1.22 (95% CI 1.08 to 1.38), and for the long-term effect was 1.10 (95% CI 0.86 to 1.40). The studies were not judged to be free from bias, and there was evidence of funnel plot asymmetry with larger studies showing smaller effects. The heterogeneity between studies was not explained by the technique used. Acupuncture was less effective than nicotine replacement therapy (NRT). There was no evidence that acupuncture is superior to psychological interventions in the short- or long-term. There is limited evidence that acupressure is superior to sham acupressure for short-term outcomes (3 trials, n = 325, RR 2.54, 95% CI 1.27 to 5.08), but no trials reported long-term effects, The pooled estimate for studies testing an intervention that included continuous auricular stimulation suggested a short-term benefit compared to sham stimulation (14 trials, n = 1155, RR 1.69, 95% CI 1.32 to 2.16); subgroup analysis showed an effect for continuous acupressure (7 studies, n = 496, RR 2.73, 95% CI 1.78 to 4.18) but not acupuncture with indwelling needles (6 studies, n = 659, RR 1.24, 95% CI 0.91 to 1.69). At longer follow-up the CIs did not exclude no effect (5 trials, n = 570, RR 1.47, 95% CI 0.79 to 2.74). The evidence from two trials using laser stimulation was inconsistent and could not be combined. The combined evidence on electrostimulation suggests it is not superior to sham electrostimulation (short-term abstinence: 6 trials, n = 634, RR 1.13, 95% CI 0.87 to 1.46; long-term abstinence: 2 trials, n = 405, RR 0.87, 95% CI 0.61 to 1.23). AUTHORS' CONCLUSIONS: Although pooled estimates suggest possible short-term effects there is no consistent, bias-free evidence that acupuncture, acupressure, or laser therapy have a sustained benefit on smoking cessation for six months or more. However, lack of evidence and methodological problems mean that no firm conclusions can be drawn. Electro
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
White,A.R., Rampes,H., Liu,J.P., Stead,L.F., Campbell,J.
Original/Translated Title
URL
Date of Electronic
20140123
PMCID
Editors
Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus 2014 RTI International, Public Health Research Division, Research Triangle Park, NC 27709, USA. Electronic address: younlee@rti.org.; RTI International, Public Health Research Division, Research Triangle Park, NC 27709, USA.; RTI International, Public Health R
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Preventive medicine
Periodical, Abbrev.
Prev.Med.
Pub Date Free Form
May
Volume
62
Issue
Start Page
14
Other Pages
19
Notes
LR: 20151119; CI: Copyright (c) 2014; JID: 0322116; OTO: NOTNLM; 2013/08/19 [received]; 2014/01/09 [revised]; 2014/01/12 [accepted]; 2014/01/16 [aheadofprint]; ppublish
Place of Publication
United States
ISSN/ISBN
1096-0260; 0091-7435
Accession Number
PMID: 24440684
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; IM
DOI
10.1016/j.ypmed.2014.01.014 [doi]
Output Language
Unknown(0)
PMID
24440684
Abstract
OBJECTIVE: Noncigarette tobacco products are increasingly popular. Researchers need to understand multiple tobacco product use to assess the effects of these products on population health. We estimate national prevalence and examine risk factors for multiple product use. METHOD: We calculated prevalence estimates of current use patterns involving cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus using data from the 2012 RTI National Adult Tobacco Survey (N=3627), a random-digit-dial telephone survey of adults aged 18 and over. Associations between use patterns (exclusive single product and multiple products) and demographic characteristics were examined using Pearson chi-square tests and logistic regression. RESULTS: 32.1% of adults currently use 1 or more tobacco products; 14.9% use cigarettes exclusively, and 6.6% use one noncigarette product exclusively, 6.9% use cigarettes with another product (dual use), 1.3% use two noncigarette products, and 2.4% use three or more products (polytobacco use). Smokers who are young adult, male, never married, reside in the West, and made prior quit attempts were at risk for multiple product use. CONCLUSIONS: Over 10% of U.S. adults use multiple tobacco products. A better understanding of multiple product use involving combustible products, like cigars and hookah, is needed. Multiple product use may be associated with past quit attempts.
Descriptors
Links
Book Title
Database
Publisher
Elsevier Inc
Data Source
Authors
Lee,Y.O., Hebert,C.J., Nonnemaker,J.M., Kim,A.E.
Original/Translated Title
URL
Date of Electronic
20140116
PMCID
Editors
Interventions for preoperative smoking cessation 2014 Abdominal Centre, 3133, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark, 2100.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
The Cochrane database of systematic reviews
Periodical, Abbrev.
Cochrane Database Syst.Rev.
Pub Date Free Form
27-Mar
Volume
(3):CD002294. doi
Issue
3
Start Page
CD002294
Other Pages
Notes
LR: 20160602; JID: 100909747; 0 (Benzazepines); 0 (Nicotinic Agonists); 0 (Quinoxalines); 6M3C89ZY6R (Nicotine); W6HS99O8ZO (Varenicline); epublish
Place of Publication
England
ISSN/ISBN
1469-493X; 1361-6137
Accession Number
PMID: 24671929
Language
eng
SubFile
Journal Article; Meta-Analysis; Review; IM
DOI
10.1002/14651858.CD002294.pub4 [doi]
Output Language
Unknown(0)
PMID
24671929
Abstract
BACKGROUND: Smokers have a substantially increased risk of postoperative complications. Preoperative smoking intervention may be effective in decreasing this incidence, and surgery may constitute a unique opportunity for smoking cessation interventions. OBJECTIVES: The objectives of this review are to assess the effect of preoperative smoking intervention on smoking cessation at the time of surgery and 12 months postoperatively, and on the incidence of postoperative complications. SEARCH METHODS: We searched the Cochrane Tobacco Addiction Group Specialized Register in January 2014. SELECTION CRITERIA: Randomized controlled trials that recruited people who smoked prior to surgery, offered a smoking cessation intervention, and measured preoperative and long-term abstinence from smoking or the incidence of postoperative complications or both outcomes. DATA COLLECTION AND ANALYSIS: The review authors independently assessed studies to determine eligibility, and discussed the results between them. MAIN RESULTS: Thirteen trials enrolling 2010 participants met the inclusion criteria. One trial did not report cessation as an outcome. Seven reported some measure of postoperative morbidity. Most studies were judged to be at low risk of bias but the overall quality of evidence was moderate due to the small number of studies contributing to each comparison.Ten trials evaluated the effect of behavioural support on cessation at the time of surgery; nicotine replacement therapy (NRT) was offered or recommended to some or all participants in eight of these. Two trials initiated multisession face-to-face counselling at least four weeks before surgery and were classified as intensive interventions, whilst seven used a brief intervention. One further study provided an intensive intervention to both groups, with the intervention group additionally receiving a computer-based scheduled reduced smoking intervention. One placebo-controlled trial examined the effect of varenicline administered one week preoperatively followed by 11 weeks postoperative treatment, and one placebo-controlled trial examined the effect of nicotine lozenges from the night before surgery as an adjunct to brief counselling at the preoperative evaluation. There was evidence of heterogeneity between the effects of trials using intensive and brief interventions, so we pooled these separately. An effect on cessation at the time of surgery was apparent in both subgroups, but the effect was larger for intensive intervention (pooled risk ratio (RR) 10.76; 95% confidence interval (CI) 4.55 to 25.46, two trials, 210 participants) than for brief interventions (RR 1.30; 95% CI 1.16 to 1.46, 7 trials, 1141 participants). A single trial did not show evidence of benefit of a scheduled reduced smoking intervention. Neither nicotine lozenges nor varenicline were shown to increase cessation at the time of surgery but both had wide confidence intervals (RR 1.34; 95% CI 0.86 to 2.10 (1 trial, 46 participants) and RR 1.49; 95% CI 0.98 to 2.26 (1 trial, 286 participants) respectively). Four of these trials evaluated long-term smoking cessation and only the intensive intervention retained a significant effect (RR 2.96; 95% CI 1.57 to 5.55, 2 trials, 209 participants), whilst there was no evidence of a long-term effect following a brief intervention (RR 1.09; 95% CI 0.68 to 1.75, 2 trials, 341 participants). The trial of varenicline did show a significant effect on long-term smoking cessation (RR 1.45; 95% CI 1.01 to 2.07, 1 trial, 286 participants).Seven trials examined the effect of smoking intervention on postoperative complications. As with smoking outcomes, there was evidence of heterogeneity between intensive and brief behavioural interventions. In subgroup analyses there was a significant effect of intensive intervention on any complications (RR 0.42; 95% CI 0.27 to 0.65, 2 trials, 210 participants) and on wound complications (RR 0.31; 95% CI 0.16 to 0.62, 2 trials, 210 participants). For bri
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Thomsen,T., Villebro,N., Moller,A.M.
Original/Translated Title
URL
Date of Electronic
20140327
PMCID
Editors
Determinants of gastroesophageal reflux disease, including hookah smoking and opium use- a cross-sectional analysis of 50,000 individuals 2014 Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran ; The Tisch Cancer Institute and Institute for Transitional Epidemiology, Mount Sinai School of Medicine, New York, New York, Uni
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
PloS one
Periodical, Abbrev.
PLoS One
Pub Date Free Form
21-Feb
Volume
9
Issue
2
Start Page
e89256
Other Pages
Notes
LR: 20150813; GR: C20/A5860/Cancer Research UK/United Kingdom; GR: Intramural NIH HHS/United States; JID: 101285081; 8008-60-4 (Opium); OID: NLM: PMC3931722; 2014 [ecollection]; 2013/11/11 [received]; 2014/01/17 [accepted]; 2014/02/21 [epublish]; epublish
Place of Publication
United States
ISSN/ISBN
1932-6203; 1932-6203
Accession Number
PMID: 24586635
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; IM
DOI
10.1371/journal.pone.0089256 [doi]
Output Language
Unknown(0)
PMID
24586635
Abstract
BACKGROUND: Gastroesophageal reflux disease (GERD) is a common cause of discomfort and morbidity worldwide. However, information on determinants of GERD from large-scale studies in low- to medium-income countries is limited. We investigated the factors associated with different measures of GERD symptoms, including frequency, patient-perceived severity, and onset time. METHODS: We performed a cross-sectional analysis of the baseline data from a population-based cohort study of approximately 50,000 individuals in in Golestan Province, Iran. GERD symptoms in this study included regurgitation and/or heartburn. RESULTS: Approximately 20% of participants reported at least weekly symptoms. Daily symptoms were less commonly reported by men, those of Turkmen ethnicity, and nass chewers. On the other hand, age, body mass index, alcohol drinking, cigarette smoking, opium use, lower socioeconomic status, and lower physical activity were associated with daily symptoms. Most of these factors showed similar associations with severe symptoms. Women with higher BMI and waist to hip ratio were more likely to report frequent and severe GERD symptoms. Hookah smoking (OR 1.34, 95% CI 1.02-1.75) and opium use (OR 1.70, 95% CI 1.55-1.87) were associated with severe symptoms, whereas nass chewing had an inverse association (OR 0.87, 95% CI 0.76-0.99). After exclusion of cigarette smokers, hookah smoking was still positively associated and nass chewing was inversely associated with GERD symptoms (all frequencies combined). CONCLUSION: GERD is common in this population. The associations of hookah and opium use and inverse association of nass use with GERD symptoms are reported for the first time. Further studies are required to investigate the nature of these associations. Other determinants of GERD were mostly comparable to those reported elsewhere.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Islami,F., Nasseri-Moghaddam,S., Pourshams,A., Poustchi,H., Semnani,S., Kamangar,F., Etemadi,A., Merat,S., Khoshnia,M., Dawsey,S.M., Pharoah,P.D., Brennan,P., Abnet,C.C., Boffetta,P., Malekzadeh,R.
Original/Translated Title
URL
Date of Electronic
20140221
PMCID
PMC3931722
Editors
Tobacco use among middle and high school students--United States, 2013 2014
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
MMWR.Morbidity and mortality weekly report
Periodical, Abbrev.
MMWR Morb.Mortal.Wkly.Rep.
Pub Date Free Form
14-Nov
Volume
63
Issue
45
Start Page
1021
Other Pages
1026
Notes
LR: 20151112; JID: 7802429; EIN: MMWR Morb Mortal Wkly Rep. 2015 Aug 28;64(33):924; ppublish
Place of Publication
United States
ISSN/ISBN
1545-861X; 0149-2195
Accession Number
PMID: 25393220
Language
eng
SubFile
Journal Article; IM
DOI
mm6345a2 [pii]
Output Language
Unknown(0)
PMID
25393220
Abstract
Tobacco use is the leading preventable cause of disease and death in the United States, and nearly all tobacco use begins during youth and young adulthood. Among U.S. youths, cigarette smoking has declined in recent years; however, the use of some other tobacco products has increased, and nearly half of tobacco users use two or more tobacco products. CDC analyzed data from the 2013 National Youth Tobacco Survey to determine the prevalence of ever (at least once) and current (at least 1 day in the past 30 days) use of one or more of 10 tobacco products (cigarettes, cigars, hookahs, smokeless tobacco, electronic cigarettes [e-cigarettes], pipes, snus, bidis, kreteks, and dissolvable tobacco) among U.S. middle school (grades 6-8) and high school (grades 9-12) students. In 2013, 22.9% of high school students reported current use of any tobacco product, and 12.6% reported current use of two or more tobacco products; current use of combustible products (i.e., cigarettes, cigars, pipes, bidis, kreteks, and/or hookahs) was substantially greater (20.7%) than use of other types of tobacco. Also, 46.0% of high school students reported having ever tried a tobacco product, and 31.4% reported ever trying two or more tobacco products. Among middle school students, 3.1% reported current use of cigars, and 2.9% reported current use of cigarettes, with non-Hispanic black students more than twice as likely to report current use of cigars than cigarettes. Monitoring the prevalence of the use of all available tobacco products, including new and emerging products, is critical to support effective population-based interventions to prevent and reduce tobacco use among youths as part of comprehensive tobacco prevention and control programs.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Arrazola,R.A., Neff,L.J., Kennedy,S.M., Holder-Hayes,E., Jones,C.D., Centers for Disease Control and Prevention (CDC)
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Perceptions and perceived impact of graphic cigarette health warning labels on smoking behavior among U.S. young adults 2014 Schroeder Institute for Tobacco Research and Policy Studies, Legacy, Washington, DC;
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Periodical, Abbrev.
Nicotine Tob.Res.
Pub Date Free Form
Apr
Volume
16
Issue
4
Start Page
469
Other Pages
477
Notes
LR: 20150422; JID: 9815751; OID: NLM: PMC3954425; 2013/11/08 [aheadofprint]; ppublish
Place of Publication
England
ISSN/ISBN
1469-994X; 1462-2203
Accession Number
PMID: 24212476
Language
eng
SubFile
Journal Article; IM
DOI
10.1093/ntr/ntt176 [doi]
Output Language
Unknown(0)
PMID
24212476
Abstract
INTRODUCTION: In 2011, the Food and Drug Administration published a final rule requiring cigarette packages and advertisements to include graphic health warning labels (HWLs) with new warning statements. Implementation of this rule has been stalled by legal challenge. This study assessed correlates of smoking-related intentions related to graphic HWLs among current cigarette smokers and nonsmokers in a national sample of U.S. young adults aged 18-34. METHODS: Data were collected from 4,236 participants aged 18-34 using an online panel in January 2012 for the Legacy Young Adult Cohort Study. Analyses were weighted to provide nationally representative estimates. Our main outcome was assessed with a single item: "Do you think that new warning labels with graphic pictures would make you think about not smoking?" RESULTS: Twenty-two percent of the young adults were current cigarette smokers. Fifty-three percent endorsed that new graphic HWLs would make them think about not smoking (40% among current smokers compared with 56% among nonsmokers). Among nonsmokers, those aged 18-24, females, Hispanics, and those who were aware of graphic cigarette HWLs were more likely to report intention to not smoke related to graphic HWLs. Among current smokers, intending to quit within the next 6 months was correlated with intention resulting from graphic HWLs. Hispanic ethnicity and intention to quit within 30 days were strong correlates of intention in light, nondaily, and self-identified social/occasional smokers. CONCLUSIONS: This study supports previous findings that graphic HWLs play an important role in preventing smoking, in addition to encouraging cessation in young adults.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Villanti,A.C., Cantrell,J., Pearson,J.L., Vallone,D.M., Rath,J.M.
Original/Translated Title
URL
Date of Electronic
20131108
PMCID
PMC3954425
Editors
Gastroprotective effects (in rodents) of a flavonoid rich fraction obtained from Syngonanthus macrolepsis 2014 Departamento de Ciencias Farmaceuticas, Centro de Ciencias da Saude, Laboratorio de Farmacologia do Trato Gastrintestinal, Universidade Federal da Paraiba (UFPB), Joao Pessoa, PB, Brazil; Departamento de Fisiologia e Biofisica, Instituto de Biologia, Univ
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
The Journal of pharmacy and pharmacology
Periodical, Abbrev.
J.Pharm.Pharmacol.
Pub Date Free Form
Mar
Volume
66
Issue
3
Start Page
445
Other Pages
452
Notes
CI: (c) 2013; JID: 0376363; 0 (Anti-Ulcer Agents); 0 (Antioxidants); 0 (Flavonoids); 0 (Plant Extracts); 0 (Sulfhydryl Compounds); 31C4KY9ESH (Nitric Oxide); OTO: NOTNLM; 2013/06/09 [received]; 2013/10/10 [accepted]; 2013/11/17 [aheadofprint]; ppublish
Place of Publication
England
ISSN/ISBN
2042-7158; 0022-3573
Accession Number
PMID: 24237033
Language
eng
SubFile
Journal Article; IM
DOI
10.1111/jphp.12175 [doi]
Output Language
Unknown(0)
PMID
24237033
Abstract
OBJECTIVES: Syngonanthus macrolepis, popularly known in Brazil as 'sempre-vivas', is a plant from the family Eriocaulaceae, it is found in the states of Minas Gerais and Bahia. The species contains a variety of constituents, including flavonoids with gastroprotective effect. In this work, a flavonoid-rich fraction (Sm-FRF) obtained from scapes of S. macrolepis was investigated for preventing gastric ulceration in mice and rats. METHODS: The activity was evaluated in models of induced gastric ulcer (absolute ethanol, stress, non-steroidal anti-inflammatory drugs and pylorus ligation). The cytoprotective mechanisms of the Sm-FRF in relation to sulfhydryl (SH) groups, nitric oxide (NO) and antioxidant enzymes were also evaluated. KEY FINDINGS: The Sm-FRF (100 mg/kg, p.o.) significantly reduced gastric injury in all models, and did not alter gastric juice parameters after pylorus ligation. CONCLUSIONS: The results indicate significant gastroprotective activity for the Sm-FRF, which probably involves the participation of both SH groups and the antioxidant system. Both are integral parts of the gastrointestinal mucosa's cytoprotective mechanisms against aggressive factors.
Descriptors
Links
Book Title
Database
Publisher
Royal Pharmaceutical Society
Data Source
Authors
Batista,L.M., de Almeida,A.B., Lima,G.R., Falcao Hde,S., Magri Lde,P., Luiz-Ferreira,A., dos Santos,L.C., Hiruma-Lima,C.A., Vilegas,W., Brito,A.R.
Original/Translated Title
URL
Date of Electronic
20131117
PMCID
Editors
Flavored-little-cigar and flavored-cigarette use among U.S. middle and high school students 2014 Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: baking@cdc.gov.; Office on Smoking and Health, National Center for Chronic
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
The Journal of adolescent health : official publication of the Society for Adolescent Medicine
Periodical, Abbrev.
J.Adolesc.Health
Pub Date Free Form
Jan
Volume
54
Issue
1
Start Page
40
Other Pages
46
Notes
LR: 20160229; CI: Published by Elsevier Inc.; GR: CC999999/Intramural CDC HHS/United States; JID: 9102136; 0 (Flavoring Agents); HHSPA722043; OID: NLM: HHSPA722043; OID: NLM: PMC4572463; OTO: NOTNLM; 2013/05/02 [received]; 2013/07/27 [revised]; 2013/07/29
Place of Publication
United States
ISSN/ISBN
1879-1972; 1054-139X
Accession Number
PMID: 24161587
Language
eng
SubFile
Journal Article; IM
DOI
10.1016/j.jadohealth.2013.07.033 [doi]
Output Language
Unknown(0)
PMID
24161587
Abstract
PURPOSE: Flavors can mask the harshness and taste of tobacco, making flavored tobacco products appealing to youth. We assessed the prevalence and correlates of flavored-little-cigar and flavored-cigarette use among U.S. middle and high school students in 2011. METHODS: Data were obtained from the 2011 National Youth Tobacco Survey, a nationally representative school-based survey of U.S. students in grades 6-12. National estimates of current flavored-little-cigar use, flavored-cigarette use, and combined use of either product were calculated overall and among current smokers by respondent characteristics, including sex, race/ethnicity, school level, and grade. Additionally, intention to quit tobacco and smoking frequency were assessed by flavored product use. RESULTS: The overall prevalence of current use was 4.2% for flavored cigarettes, 3.3% for flavored little cigars, and 6.3% for either product. Among current cigar smokers, 35.9% reported using flavored little cigars, and among current cigarette smokers, 35.4% reported using flavored cigarettes. Among current cigar or cigarette smokers, 42.4% reported using flavored little cigars or flavored cigarettes. Flavored product use among current smokers was higher among non-Hispanic whites than among blacks and Hispanics, higher among high school students than middle school students, and increased with grade. Among cigar smokers, prevalence of no intention to quit tobacco was higher among flavored-little-cigar users (59.7%) than nonusers (49.3%). CONCLUSIONS: More than two fifths of U.S. middle and high school smokers report using flavored little cigars or flavored cigarettes, and disparities in the use of these products exist across subpopulations. Efforts are needed to reduce flavored tobacco product use among youth.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
King,B.A., Tynan,M.A., Dube,S.R., Arrazola,R.
Original/Translated Title
URL
Date of Electronic
20131022
PMCID
PMC4572463
Editors
Prevalence of marijuana use at college entry and risk factors for initiation during freshman year 2014
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Addictive Behaviors
Periodical, Abbrev.
Addict.Behav.
Pub Date Free Form
Jan
Volume
39
Issue
1
Start Page
302
Other Pages
307
Notes
LR: 20150515; GR: R01 CA141643/CA/NCI NIH HHS/United States; GR: R01CA141643/CA/NCI NIH HHS/United States; JID: 7603486; NIHMS532494; OID: NLM: NIHMS532494; OID: NLM: PMC4098711; ppublish
Place of Publication
England
ISSN/ISBN
1873-6327; 0306-4603
Accession Number
PMID: 24455784
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Extramural; IM
DOI
Output Language
Unknown(0)
PMID
24455784
Abstract
BACKGROUND: Marijuana is currently the most commonly used drug on college campuses. Marijuana use among college students is increasing, and many students begin using marijuana during college. The goal of this study was to investigate predictors of lifetime marijuana use at college entry and initiation during freshman year. METHODS: We used responses from the first two semesters of a longitudinal study of 3146 students from 11 colleges in North Carolina and Virginia. Random-effects logistic regression models were constructed to identify factors that predict lifetime marijuana use at college entry and initiation during freshman year. RESULTS: Nearly 30% of students reported ever having used marijuana at college entry. Among students who had never used marijuana prior to college, 8.5% initiated use during freshman year. In multivariable logistic regression models, having at least $100 per month in spending money; attending church rarely or never; current use of cigarettes, alcohol, and hookah tobacco; lifetime use of other illicit drugs; and a higher propensity toward sensation seeking were associated with a higher likelihood of having used marijuana at least once at college entry. Hispanic ethnicity, living on campus, and current use of cigarettes and alcohol were associated with a higher likelihood of initiating marijuana use during freshman year. CONCLUSION: These results have implications for targeting substance abuse prevention programs on college campuses.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Suerken,C.K., Reboussin,B.A., Sutfin,E.L., Wagoner,K.G., Spangler,J., Wolfson,M.
Original/Translated Title
URL
Date of Electronic
PMCID
PMC4098711
Editors